Top Broker Regulation Stories
Drug costs are 3X in the U.S. what other countries pay, study finds
By Scott WooldridgeIndustry observers said that drug companies are likely to continue to oppose the government's efforts to reduce prices.
Brokers, human resources manager and other benefits professionals were thrust into the regulatory environment with the passage of the Affordable Care Act in 2010. As health care reform continues to evolve in a post-ACA world, we provide updates on the legislative front, and analysis and advice regarding the current regulatory environment, along with insights into what's next.
Industry observers said that drug companies are likely to continue to oppose the government's efforts to reduce prices.